0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2016;315(21):2267. doi:10.1001/jama.2016.5897.

Editorial | 
Shailender Bhatia, MD; John A. Thompson, MD
JAMA. 2016;315(15):1573-1575. doi:10.1001/jama.2016.4012.

Original Investigation | 
Antoni Ribas, MD, PhD; Omid Hamid, MD; Adil Daud, MD; et al.
JAMA. 2016;315(15):1600-1609. doi:10.1001/jama.2016.4059.
Includes: Supplemental Content

Research Letter | 
Ann Marie Navar, MD, PhD; Michael J. Pencina, PhD; Jennifer A. Rymer, MD; et al.
JAMA. 2016;315(12):1283-1284. doi:10.1001/jama.2016.2374.

Preliminary Communication | 
N. Jewel Samadder, MD, MS; Deborah W. Neklason, PhD; Kenneth M. Boucher, PhD; et al.
JAMA. 2016;315(12):1266-1275. doi:10.1001/jama.2016.2522.
Includes: CME, Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(21):2227. doi:10.1001/jama.2015.15988.

Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2015;314(20):2117-2119. doi:10.1001/jama.2015.10795.

Viewpoint | 
James P. Allison, PhD
JAMA. 2015;314(11):1113-1114. doi:10.1001/jama.2015.11929.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;313(21):2114. doi:10.1001/jama.2015.5670.

Viewpoint | 
Euan A. Ashley, MRCP, DPhil
JAMA. 2015;313(21):2119-2120. doi:10.1001/jama.2015.3595.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Viewpoint  | 
The “Next Big Thing” in Treatment for Relapsed or Refractory Multiple Myeloma May Be Held Back by Design—Between the Lines
Kai Ruggeri, PhD; Áine Maguire, MSc; Gordon Cook, MD